Navigation Links
Roskamp Institute to Begin Human Alzheimer's Clinical Trials With a Natural Compound in Tobacco
Date:10/7/2010

SARASOTA, Fla., Oct. 7 /PRNewswire-USNewswire/ -- Today the Roskamp Institute said that it is pleased to announce that it will soon begin clinical trials of RCP-006, a compound found in tobacco, for the treatment of Alzheimer's disease. The compound was developed by Rock Creek Pharmaceuticals, a subsidiary of Star Scientific in Virginia, and made available to Roskamp through its affiliate, SRQ Bio, LLC.

In laboratory tests with cells, the compound, RCP-006, a natural product, inhibits inflammation and the production of amyloid, both of which cause Alzheimer's disease.  Previous studies have shown that certain tobacco components may be protective against Alzheimer's disease, but the mechanism was unknown and the negative effects of smoking and tobacco use outweigh these positive benefits.  RCP-006, one of the many compounds found in tobacco, is believed to be responsible for some of the positive medicinal effects of smoking and tobacco use.  In addition to the new clinical trials, Roskamp scientists are working with researchers at Johns Hopkins School of Medicine for other medical applications of RCP-006. RCP-006 is found in the Solanaceae plant family that includes tomatoes, peppers and eggplant, but RCP-006 is very prevalent in tobacco. Roskamp Institute Director, Dr. Michael Mullan, said, "It's ironic that a compound with the potential medical benefits of RCP-006 was hidden in tobacco."

Alzheimer's disease is impacting 5.3 million people in the United States and women have higher risk of getting this devastating disease than men. The economic burden of Alzheimer's in the U.S. is estimated to be $172 billion annually.  

The Roskamp Institute is a non-profit organization devoted to understanding causes and finding cures for neuropsychiatric and neurodegenerative disorders. The Institute utilizes a broad range of scientific approaches to understanding the causes of and potential therapies for these disorders with an emphasis on Alzheimer's disease. For more information, please call (941) 752-2949.

SRQ Bio, LLC, a for-profit affiliate of the Roskamp Institute, has a financial interest in Star Scientific. In April 2010, Star Scientific issued to SRQ Bio, LLC 100,000 shares of common stock in a private placement.  In addition, in March 2010, Robert Roskamp, the trustee of the Roskamp Institute, in an individual capacity, purchased shares of Star Scientific stock valued at $1 million, and was issued a matching warrant for an equal number of shares, as part of a private placement transaction.

http://www.rfdn.org


'/>"/>
SOURCE Roskamp Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
2. Roskamp Institute Identifies New Class of Drugs to Treat Alzheimers Disease
3. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
4. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
5. American College of Surgeons Health Policy Research Institute Releases Surgery Workforce Atlas That Shows Surgeon Shortage Across the U.S.
6. Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100.
7. The Colorado Institute for Drug, Device and Diagnostic Development Announces Companies Selected From Its First Solicitation: Sophono, Inc., Receiving $600K; and PeptiVir, Inc., $300K
8. National Pharmaceutical Council Comments on Patient-Centered Outcomes Research Institute Board of Governors
9. Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources
10. National Institutes of Health Chooses ScriptPro for Pharmacy Automation
11. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)...  A new study by a pair of Geisinger ... therapy to treat chronic pain is not only ineffective, ... consequences, including death. Palliative care physicians ... , M.D., authored the study which provides a review ... study was published in the December 2016 edition of ...
(Date:12/8/2016)... Information products and services provider Elsevier has launched ... world,s largest abstract and citation database of peer-reviewed literature, providing the ... 5,000 publishers. The new set of metrics will improve decisions on ... adjust a journal,s editorial strategy. ... , CiteScore metrics comprise ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia ... 1, 2017. The name change aligns the entire company with its existing ... care quality. , “We are very proud of the achievements associated with the ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health ... . , Results of the comparative usability study demonstrate that a dictation-based method ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation , a ... other pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to ... president of sales. , Litsinger joined Mirixa in 2008 after serving as ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
Breaking Medicine News(10 mins):